A new wave of change in the field of colorectal neoplasms and colonoscopy is here, leading to the work in colonoscopic resection to begin anew. Nonpolypoid colorectal neoplasms (NP-CRN) are now widely recognized in Western countries (Fig. 36.1).¹ This finding requires numerous paradigm shifts in our clinical, educational, and research activities. The detection and diagnosis of NP-CRN necessitates the search for subtle nonprotruding findings during colonoscopy.² Treatment of NP-CRN requires mucosal resection technique, which is more complex than polypectomy. Because nonpolypoid neoplasms can be found throughout the gastrointestinal (GI) tract, all endoscopists must become familiar with endoscopic mucosal resection (EMR) techniques, and future generations must understand its theoretical basis, obtain the dexterity to perform it, and perfect it. Knowledge about the biology and outcomes of the management of nonpolypoid GI neoplasms is to be acquired. Within the same period of time, new technology—high definition, high magnification, and image-enhanced endoscopy³—that is useful for the detection, diagnosis, and treatment of NP-CRN has become available and is increasingly employed. The technique of submucosal dissection, which has become a standard resection technique for early gastric cancer in Japan, is also being applied for the resection of certain types of colorectal neoplasms to achieve R0 resection—curative en bloc resection with all margins being free of neoplasms (Fig. 36.2)⁴—without surgery.

Fig. 36.1 A, Nonpolypoid colorectal neoplasm (NP-CRN) (slightly elevated) in the sigmoid colon. B and C, The border and surface pattern of the lesion were examined with image-enhanced endoscopy techniques using narrow band imaging (B) and diluted indigo carmine (C). The lesion was resected using mucosal resection technique; pathology showed adenoma.

Fig. 36.2 General classification of methods of resection of colorectal lesions.

Advances in the ability to detect, diagnose, and treat all types of colorectal neoplasms are important. These advances provide hope that the benefit of colonoscopy screening to prevent colorectal cancer, one of the most common causes of cancer death worldwide, can be extended further. In the United States, it was estimated that there would be approximately 146,970 new cases of colorectal cancer in 2009 and 49,920 deaths caused by the disease. The lifetime risk of developing colorectal cancer in the U.S. population is about 6%, with 90% of cases occurring in individuals older than 50 years. The U.S. incidence of colorectal cancer is slightly higher in men than in women, but because women live longer than men, the total number of cases is higher in women. Colorectal cancer incidence and mortality also vary by race and ethnicity, with the highest rate occurring in African Americans; an intermediate rate occurring in whites and Asian/Pacific Islanders; and the lowest rates occurring in American Indians, Alaska Natives, and Hispanics.⁵ Most colorectal cancer deaths are believed to be preventable with screening colonoscopy and polypectomy.⁶ The paradigm that a significant majority of colorectal cancers are thought to arise through the adenoma-to-carcinoma sequence⁷ has been expanded with mismatch repair, serrated, and hybrid pathways.⁸

Neoplasms can be both polypoid and nonpolypoid, and NP-CRN has a higher risk to contain high-grade dysplasia or submucosal invasion at the time of colonoscopy compared with polypoid neoplasm.^1,^9,¹⁰ It has been estimated that 25% to 40% of adults older than 50 years in the United States have at least one adenoma and that a small fraction of these adenomas progresses to cancer. Because it is impossible to predict which adenoma will become malignant, physicians attempt to remove all adenomas during colonoscopy. The National Polyp Study, which showed that removal of adenomas during screening colonoscopy can decrease the subsequent development of colorectal cancer by 90% compared with historical controls, provided a level of support to this current standard of practice.⁶ It is our dream to be able to prevent the development of advanced cancer safely and efficaciously in every patient we treat.

Endoscopically, adenomas and early colorectal cancer can be classified as polypoid (protruded) and nonpolypoid (superficial) types (Fig. 36.3).¹¹ Colonoscopic polypectomy can be used to remove polypoid lesions. Colonoscopic mucosal resection, using the inject and cut technique, is a safe and efficacious technique used to remove nonpolypoid or sessile lesions. Colonoscopic submucosal dissection technique, which is used to remove diseased mucosa by dissecting through the middle to deeper layers of the submucosa, can refine our ability to remove lesions that are difficult, if not impossible, to remove using mucosal resection technique. In this chapter, we provide an in-depth survey of colonoscopic resection of polypoid and nonpolypoid colorectal lesions.

Fig. 36.3 Macroscopic classification of early neoplastic lesions of the colon and rectum. This classification provides a more precise schematic description of early neoplastic lesions. In addition to the commonly described pedunculated, semipedunculated, and sessile lesions, the classification provides the appropriate descriptors for flat and depressed lesions. The classification is particularly useful for the endoscopist in deciding treatment strategy of early colorectal carcinomas because the risk of submucosal invasion of these lesions corresponds to the endoscopic appearance and size. Image-enhanced endoscopy is useful to study the surface details and border of the nonprotruding type.

Differential Diagnosis

Colonic lesions are classified as either epithelial or nonepithelial. Epithelial lesions include neoplastic adenomas (serrated, tubular, tubulovillous, villous), carcinomas, and nonneoplastic polyps (hyperplastic, juvenile, hamartoma, inflammatory). Occasionally, numerous lesions are encountered during colonoscopy of patients who have polyposis syndromes, including familial adenomatous polyposis (adenomas), Peutz-Jeghers syndrome (hamartomas), juvenile polyposis (juvenile polyps), or Cowden’s syndrome (hamartomas). In addition, patients with hereditary nonpolyposis colorectal cancer may harbor multiple advanced neoplastic lesions. Nonepithelial colonic lesions typically arise in the submucosal, muscularis propria, or serosal layers of the colonic wall and include lipomas, leiomyomas, carcinoids, lymphomas, and metastatic tumors. Indentations of the colonic wall by adjacent organs or endometrial implants on the serosa can also have the appearance of subepithelial lesions.

Careful endoscopic observation of the surface features of the lesion can often allow differentiation of epithelial from nonepithelial origin because nonepithelial lesions are usually covered by normal mucosa. With current videocolonoscopes, and especially with the addition of image enhancement and magnification endoscopy,¹² it is increasingly possible to distinguish reliably among hyperplastic polyps, adenomatous polyps, and superficial early adenocarcinomas. Colonoscopic resection may be viewed as a diagnostic procedure. Removal of the entire lesion, when possible, provides the most rigorous evidence that a malignancy was not missed, as it might be because of sampling error with standard biopsies. These procedures provide the definitive treatment when the lesions are removed completely. Subepithelial lesions sometimes can be removed safely when they are located above the muscularis propria, as evidenced by their endoscopic appearance, response to submucosal saline injection, and, if needed, endoscopic ultrasound (EUS). Generally, biopsy should be performed if possible in lesions that are not amendable to endoscopic resection to ascertain their histology, and the lesions should be endoscopically marked for surgical planning with submucosal tattoo and radiopaque clips.

Clinical Features and Pathology

The macroscopic classification of adenomas and early colorectal neoplasms is crucial in the discussion of diagnosis and treatment of early colorectal cancer.^11,¹³ The classification by the Japanese Society for Cancer of the Colon and Rectum can provide a common descriptor of adenomas and early colorectal cancer (mucosal or submucosal cancer, regardless of lymph node status). The Paris classification has been promoted for worldwide use¹⁴—although a derivative from the Japanese categorization, its slight alterations in morphologic definitions make it difficult to infer directly the knowledge that has been meticulously collected by our Japanese colleagues. The application of a standard classification of colorectal lesions is the first step in stratifying which lesions are more likely to contain advanced pathology.

Based on their endoscopic appearance, we classify adenomas and early colorectal cancers as polypoid and nonpolypoid. The polypoid type consists of pedunculated, semipedunculated, and sessile polyps. The nonpolypoid type consists of superficially elevated, flat, and depressed lesions. Excavated superficial colorectal neoplasms are rarely observed. Superficially elevated nonpolypoid lesions are differentiated from sessile polypoid lesions both endoscopically (the height of the lesion is less than half the diameter) and histologically (the thickness of the lesion is less than twice that of the adjacent normal mucosa).¹⁵ The term flat is often used to describe superficially elevated lesions. In the colon, however, flat generally connotes that the surface is flat, rather than that the lesion is at the same level as the surrounding mucosa (in the colon and rectum, in contrast to in the esophagus, early neoplastic lesions are rarely at the same level as the surrounding mucosa.)

In the Japanese literature and increasingly becoming common worldwide, flat lesions (IIa) larger than 10 mm are also called laterally spreading tumors (LST), although the term refers more to the growth pattern rather than the endoscopic appearance. In the United States, these large flat lesions are often called carpet lesions. LST with nodular or coarsely granular surfaces are called LST-granular. Other LST are called LST-nongranular. This distinction is important because LST-nongranular are more likely to contain invasive cancer, which is more difficult to assess endoscopically. LST-nongranular are also more difficult to resect and may require en bloc resection to ensure cure. In the Paris classification, semipedunculated lesions are lumped into the pedunculated category, and flat lesions are defined as lesions with height less than a closed biopsy forceps. Depressed nonpolypoid lesions, although rare, accounted for almost one-third of the invasive early cancers that were resected endoscopically by Kudo and colleagues,¹⁶ who observed more than 14,000 colorectal lesions. Confirmatory reports have been published.^12,¹⁷ Epidemiology studies of flat and depressed lesions in Western countries have also shown that depressed lesions have a high likelihood of containing invasive cancer (Table 36.1).¹⁸ More than 40% of small (6 to 10 mm) depressed lesions contain submucosal invasive cancer; virtually all large (>2 cm) depressed lesions have submucosal invasion (Table 36.2).¹⁶ In comparison, submucosal invasive cancer is rare in flat lesions smaller than 10 mm. The risk increases to about 30% in LST larger than 2 cm. Protruding (polypoid) lesions have the lowest rate—slightly greater than 2%—of submucosally invasive cancer.¹⁶

Table 36.1 Series of Flat and Depressed (F&D) Neoplasms in Patients from Western Countries

Table 36.2 Risk for Submucosal Invasions Correlated with Endoscopic Appearance and Size of Colorectal Lesions

Indications and Contraindications

Indications

Endoscopists most commonly resect polypoid lesions using either a snare loop or a biopsy forceps. The malignant potential of an individual polyp is not fully known, and all polyps except diminutive hyperplastic-appearing polyps in the sigmoid and rectum are removed from otherwise healthy patients. However, the risks of polypectomy must also be considered. Treatment decisions must consider whether substantial risks exist and whether the patient’s overall life expectancy is unlikely to be affected by the generally slow progression of colonic adenomas. The application of principles of statistics whereby the risks considered include the confidence interval must be used at the bedside (see later section). The natural history of progression through the adenoma to carcinoma sequence is estimated to be approximately 10 years,²⁶ so patients with advanced comorbid illnesses and limited life expectancy may not benefit from adenoma resection.

Colonoscopic Polypectomy

Generally, diminutive polyps measuring up to approximately 6 mm in diameter are easily removed with or without cautery, with use of a biopsy forceps or a snare. Intermediate sized and larger polyps are most commonly resected via a snare with monopolar cautery, although sessile polyps up to 1 cm can be removed by snare polypectomy with cautery (cold snare). Removal of large polyps may require piecemeal rather than single piece resection and prophylaxis against postpolypectomy bleeding. In addition, when polyps are sessile and particularly when the endoscopic appearance suggests the presence of superficial carcinoma, colonoscopic mucosal resection can be useful to achieve an appropriate submucosal cutting plane and resection margin.

Colonoscopic Mucosal Resection and Submucosal Dissection

Colonic mucosal resection is indicated for resection of nonpolypoid and sessile polypoid adenomas in which resection at the submucosal plane is required to obtain accurate pathology and cure. For lesions suspected to contain high-grade dysplasia or superficial submucosal invasive cancer, mucosal resection is indicated if the lesion can be removed en bloc. Otherwise, submucosal dissection or surgery (after confirmatory biopsy) is indicated. The indications of colonoscopic mucosal resection and submucosal dissection are presented in Box 36.1. Nonpolypoid lesions can be difficult to capture with standard snare and polypectomy techniques. It may be impossible to perform en bloc resection of large flat lesions using standard polypectomy techniques. The application of electrocautery may lead to a burn into the muscularis propria. Resection of large sessile lesions carries similar risks. Mucosal resection technique using submucosal injection can ameliorate these technical difficulties and risks. Depressed lesions, including small ones, are most likely to contain submucosally invasive cancer. Complete removal of small depressed lesions is the only way to determine accurately that invasive carcinoma is not present.

Box 36.1 Indications for Colonoscopic Mucosal Resection and Submucosal Dissection

I A team to perform EMR or submucosal dissection safely and efficaciously is available.

II The neoplasm does not have features of massive submucosal or advanced invasion.

III EMR:

A Mucosal resection: Lesion (nonpolypoid or sessile) with adenomatous-appearing or villous adenomatous–appearing mucosa requiring resection at the submucosa to ensure cure. If the lesion is suspected to contain high-grade dysplasia or slight submucosal invasion, EMR is indicated, provided that the lesion is within the scope of EMR technique for en bloc removal.

B Submucosal dissection: Lesion requiring en bloc resection beyond the scope of EMR:

1 Large, flat, nongranular lesion with slight depression

2 Large, flat, granular or sessile lesion suspected to contain high-grade dysplasia or slight submucosal invasion

3 Larger depressed lesions

IV Pathologic evaluation provided proof of cure:

A Well-differentiated carcinoma (without poorly differentiated)

B Without lymphatic or vascular invasion

C Intramucosal cancer, regardless of size (limit of involvement in the United States)

D Minute submucosal invasion less than 1000 µm from the muscularis mucosa, or if the muscularis mucosa is absent, depth of measurement is performed from the surface of lesion (limit of involvement in Japan)

E Vertical and lateral margins are from carcinoma

EMR, endoscopic mucosal resection.

Because Western pathologists rely primarily on evidence of invasion to diagnose invasive carcinoma (as opposed to cellular and glandular morphology, as is common in Japan), mucosal resection technique is more appropriate to obtain a complete sample of small depressed lesions. The superficial submucosa is typically included in these resection specimens, allowing the pathologist to assess for submucosal invasion. Larger true depressed lesions often are invasive carcinoma. After a confirmatory biopsy and tattooing of the site, these lesions may be best managed with surgery. Mucosal resection is also used increasingly to remove submucosal lesions,²⁷ especially small (<1 cm) rectal carcinoids, where the risk of metastasis is low.^28,²⁹

Contraindications

Colonoscopy is usually inappropriate in patients who are pregnant ³⁰ or have fulminant colitis, suspected intestinal perforation, fresh intestinal anastomosis, or recent myocardial infarction. Polypectomy and mucosal resection generally should not be performed in patients who have uncorrected bleeding disorders. Although polypectomy and mucosal resection were reported in one study to be relatively safe in lesions smaller than 1 cm, the technique used in that study involved submucosal injection before snaring and clipping to approximate the mucosal defect. Good bowel preparation is crucial for detection of subtle lesions and for resection of particularly large or difficult lesions when an elevated risk of perforation exists. Poor bowel preparation is also a contraindication for performance of complex polypectomy or mucosal resection.

Anticoagulation Therapy

Patients need individualized assessment, balancing the risks of interrupting anticoagulation for colonoscopic polypectomy or mucosal resection against the risks of significant bleeding during and after the procedure.^31,³² Patients at very high risk for thrombotic events, such as patients with recent coronary stent placements, should simply defer elective endoscopy until the thrombotic risk is lower. The American Society for Gastrointestinal Endoscopy (ASGE) has developed guidelines for management of anticoagulation.^33,³⁴ Generally, patients at relatively low risk of thromboembolic complications can discontinue warfarin 5 days before the procedure and resume it shortly after standard polypectomy or 7 to 10 days after complex polypectomy or mucosal resection. The international normalized ratio should be 1.4 or less before polypectomy or mucosal resection of a large lesion. High-risk patients, such as patients with atrial fibrillation and concomitant valvular disease, should receive either standard intravenous heparin until approximately 6 hours before the procedure or low-molecular-weight heparin until approximately 24 hours before the procedure. Warfarin generally can be resumed on the night after the procedure with use of intravenous heparin resumed earlier at 2 to 6 hours after the procedure until the international normalized ratio is therapeutic.

Standard heparin has a short half-life compared with low-molecular-weight heparin, so it permits swift immediate reversal of anticoagulation should patients develop postpolypectomy bleeding. In our published experience of colonoscopic resection of small (<1 cm) colorectal lesions in anticoagulated patients, we withheld warfarin for approximately 36 hours only to avoid supratherapeutic anticoagulation resulting from dietary restriction and bowel purge. In this retrospective series, using various polypectomy techniques, including cold snare, standard snare with cautery, and inject and cut mucosectomy, followed by endoscopic clipping, the risk of major delayed bleeding in the resection of 5.1 ± 2.2 mm lesions was 0.8% (95% confidence interval 0.1% to 4.5%).³⁵

Aspirin, Nonsteroidal Antiinflammatory Drugs, and Antiplatelet Medications

Limited data from the literature suggest that aspirin and other nonsteroidal antiinflammatory drugs (NSAIDs) in standard doses do not increase the risk of significant bleeding after colonoscopic polypectomy. ASGE recommends proceeding with standard polypectomy in patients taking these medications.^33,³⁴ We are unaware, however, of any recommendations regarding polypectomy or mucosal resection of large or complex lesions. In our practice, patients with significant coronary disease continue to take aspirin, 81 mg/day, after large polypectomy or mucosal resection. The ASGE guidelines for management of platelet aggregation inhibitors, such as ticlopidine and clopidogrel, recommend discontinuation of these agents for 7 to 10 days. Patients receiving combination therapy (e.g., clopidogrel and aspirin) may be at an additional risk of bleeding. Reinstitution of antiplatelet agents should be individualized. Generally, when we believe that the risk of bleeding after endoscopic removal of a large or complex lesion is significant, we recommend that patients refrain from taking other NSAIDs and platelet inhibitors 7 days before the procedure and for 7 to 14 days after it.

Antibiotic Prophylaxis for Endocarditis

The ASGE and the American Heart Association guidelines state that antibiotic prophylaxis solely to prevent infective endocarditis is no longer recommended before endoscopic procedures, including diagnostic colonoscopy and colonoscopic polypectomy.³⁶

Instruments

Snare Loop

Both the endoscopist and the endoscopy assistant must be familiar with the type of snare used. These individuals must understand and have tactile knowledge of the opening and closing of the snare, the closing pressure required to produce optimal coagulation, and the relationship between the size of the tissue being strangulated and the amount of snare being closed. Various snares, each with a slightly different feature, are used for polypectomy and mucosal resection. The choice is made based on personal preference, the size of the lesion, and the technique being used. The minisnare is often used for small polyps, and larger snares are used for larger polyps. Stiffer snares are used for colonoscopic mucosal resection so that flat or depressed lesions can be captured in the snare.^27,³⁷

Electrocautery

High-frequency electrical current is employed to facilitate cutting and to coagulate vessels at the resection margin. Colonoscopic resection is typically performed with a monopolar snare. The metallic conducting snare serves as the active electrode, and the circuit is completed via a conducting grounding pad that is affixed to the patient’s skin. In the case of polypectomy, when the snare grasps the polyp, electrical current is applied as the snare is closed to transect the stalk. Electrical current traveling through tissue heats it. The amount of heat transferred to each point in the tissue (per unit time) is given by the product of the square of the current density and the resistance. The current density is the amount of current passing through a unit area. Although the same total current passes through the stalk of the polyp and the grounding pad, the current density is much higher at the stalk because the cross-sectional area is smaller. As a result, the stalk is cauterized while the bowel wall and the rest of the patient’s body generally are left untouched (Fig. 36.4).³⁸

Fig. 36.4 The concept of electrocautery is important to master. In this case, application of understanding of the concept of current density—the amount of current per unit area—is shown. A, Current density is highest at the plane with the smallest area, in this case, cross-sectional area that has been strangulated by the loop (arrow). The ideal way to snare a pedunculated polyp that has been looped is to tighten the snare as much as possible to make the snared plane smaller than the plane that has been looped. B, Care is given to snare with adequate distance from the deployed loop. C, In this case, the snare was not closed tighter than the loop, and cautery also occurred at looped area. This case also provides a reason to deploy the loop slightly away from the wall of the colon to prevent accidental coagulation necrosis.

High-frequency electrical current greater than 300 kHz (300,000 cycles/sec) is used because lower frequencies can stimulate muscles, nerves, and the heart. The effect of the current on the tissue depends on the temperature achieved in the tissue, which depends on the shape of the electrode, the duration and waveform of the current, and the voltage. At temperatures between 50° C and 70° C, irreversible cell damage occurs. Between 70° C and 100° C, the tissue is coagulated; collagen is converted to glucose, and the glucose causes the coagulated tissue to become sticky. At temperatures greater than 100° C, the tissue is desiccated; intracellular and extracellular water is vaporized, and the tissue dries out, shrinks, and becomes sticky. During polypectomy, these effects are visualized as a shrinking and whitening of polyp stalks. If low peak voltage (<200 V) is used, the tissue is devitalized, coagulated, and desiccated. As the tissue is dehydrated, the resistance increases until current can no longer flow and no further heat ensues. In this mode, there is little or no cutting; in some clinical situations, the snare can become entrapped in the desiccated tissue.

For efficient electrosurgical cutting, temperatures greater than 500° C are required. At these high temperatures, intracellular and extracellular water is vaporized rapidly, and the cellular architecture is disrupted by steam pressure. Electrosurgery units generate vaporization by producing electrical arcs that jump between the active electrode (snare) and the tissue. The electrical arcs focus the current on a small area on the tissue and result in a locally very high current density and temperature. At least 200 V are required to generate these electrical arcs; if the tissue is partially desiccated, the voltage required is substantially higher. Electrosurgical cutting is ideally performed without contact between the electrode and the tissue, leaving room for proper arcing to form; cutting occurs without mechanical pressure as tissue is vaporized.

During colonoscopy, the snare is typically in contact with the tissue. This contact can lead to lower resistance and high current, causing an inappropriate decrease in voltage that prevents electrical arcs from forming. The result is an unintended coagulation effect without cutting. Newer cautery units, such as the ERBE (Marietta, GA), automatically supervise the initial phase of cutting and provide the necessary current and voltage to ensure proper arcing. During electrosurgical cutting, there is also a coagulation effect, which depends on factors such as the electrode thickness and voltage. Thin electrodes (e.g., a needle-knife), low voltages, and rapid cutting result in little coagulation. Thicker electrodes (e.g., a thick snare loop) and higher voltages result in more intense coagulation. Uncontrolled rapid cutting with minimal coagulation can occur if mechanical pressure (e.g., by closing the snare rapidly) is applied; this phenomenon is also familiar to endoscopists from endoscopic retrograde cholangiopancreatography sphincterotomy, where it is called a “zipper” cut.

Most electrocautery units allow the endoscopist to choose between various cautery modes that are designed to produce predominantly cutting, predominantly coagulation, or a blend of both. However, factors such as the power level, tissue resistance, and speed of snare closure can alter the effect of the cautery. The “cutting” mode delivers a continuous sine-wave voltage pattern. When sufficient voltage is delivered to create electrical arcing, electrosurgical cutting ensues. “Coagulation” and “blended” modes actually deliver a higher voltage, but the delivery is intermittent: short pauses separating brief bursts of delivery. The duty cycle (the total proportion of time that current is delivered) is typically between 5% and 50% in coagulation modes and between 50% and 80% in blended modes. The higher voltages allow deeper coagulation during cutting, particularly in “coagulation” mode. An additional effect, fulguration (spray coagulation), can occur with very high voltages and low duty cycles when a series of random electrical arcs carbonize the tissue.

The use of submucosal injection during mucosal resection promotes a better distribution of current because the current can fan out from the resection site to the wide saline cushion. This fan out reduces thermal damage to the larger submucosal vessel and part of the colon wall immediately beneath the lesion.³⁹

Argon Plasma Coagulation

Argon plasma coagulation (APC) is often used after EMR to cauterize the resection margins.⁴⁰ APC produces electrically conducting argon plasma by guiding argon gas through a delivery catheter that also contains an electrode for delivery of high-frequency current. APC generally creates uniformly deep zones of desiccation, coagulation, and devitalization that measure less than 3 mm deep in total. Because the argon plasma conducts the current, APC can be applied without tissue contact.⁴¹^–⁴³ In a randomized, controlled study, prophylactic APC to nonbleeding visible vessels at the en bloc polyp (5 to 20 mm) resection sites did not significantly decrease the rate of delayed postpolypectomy bleeding (4.3% in the control group vs. 2.5% in the APC group). The study excluded resections of pedunculated polyps, polyps smaller than 5 mm or larger than 20 mm, polyps that had immediate bleeding, and polyps with no vessels visible at the postresection site.⁴⁴

Bipolar Instruments

Bipolar instruments, in which current flows between two electrodes in the instrument rather than from one electrode to a grounding pad, have the potential advantage of avoiding damage to deeper structures. Bipolar polypectomy snares are not currently widely used, although more recent studies have shown their potential utility in colonoscopic submucosal dissection. Bipolar coagulation devices are commonly used to treat bleeding vessels in peptic ulcer disease, and they can be employed to treat bleeding areas after polypectomy, although mechanical hemostasis using clipping or looping has been shown to be efficacious with perhaps less risk of perforation. Sufficient mechanical pressure should be applied to the vessel to compress it during cauterization, to prevent heat dissipation by flowing blood.

Other Instruments

Other instruments that are often used during polypectomy and mucosal resection include the standard sclerotherapy injection needle, endoclip,^44,⁴⁵ endoloop,⁴⁶^–⁴⁸ Roth net,⁴⁹ and Tripod. Detailed examples of use of these instruments, which are important for colonoscopic resection, are described subsequently in the Techniques section.

Techniques

Adequate bowel preparation is important; split dosing of bowel preparation is very useful to clean the bowel adequately for the detection and diagnosis of NP-CRN and resection of all types of appropriate lesions. Techniques to prevent looping of the colonoscope during insertion are essential.⁵⁰ Familiarity with the patient, staff, equipment, and accessories is required. Various techniques are available to perform sophisticated colonoscopic polypectomy, mucosal resection, and submucosal dissection. These techniques, designed to increase the safety of resection, have allowed resections of lesions that in the past would have been accomplished through surgery. Interpretation of the pathology is vital, and preparation of the pathologic specimen requires the participation of the endoscopists at the completion of the procedure.